格隆汇11月21日丨雅各臣科研制药(02633.HK)公告,截至2024年9月30日止6个月来自持续经营业务的收益约为8.1亿港元,较2023年同期增加约13.3%。同期来自持续经营业务的溢利约为1.4亿港元,较2023年同期增加约44.2%。董事会宣派截至2024年9月30日止6个月的中期股息每股普通股3.5港仙(总额约为70.0百万港元),较2023年同期每股普通股2.5港仙增加约40.0%(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.